We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T Turnover 8.34%
1-Year Est. Return 35.08%
 

Morgan Stanley is a financial services company with divisions for institutional services, wealth management and investment management. Its institutional arm advises large institutions on strategy and raising capital, its wealth arm serves individuals and family offices and runs the E-Trade self-directed investing service, and its investment arm offers hedge fund, real estate and infrastructure strategies as well as private equity and private credit. It was founded in 1935 by Harold Stanley and Henry Sturgis Morgan, who was J.P. Morgan's grandson, both leaving J.P. Morgan & Co., after the Glass-Steagall Act forced commercial and investment banking apart. In 1997 it merged with Dean Witter Discover, the financial services business Sears had spun off, and it went back to the Morgan Stanley name in 2001. In 2009 its wealth business was merged with Citigroup's Smith Barney, and in 2012 Morgan Stanley bought a larger share of that venture from Citigroup. Morgan Stanley later bought E-Trade in 2020 and Eaton Vance in 2021.

This Fund
S&P 500
This Quarter Est. Return
+21.2%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+494.77%
AUM
$1.89T
AUM Growth
+$231B
Cap. Flow
+$19.1B
Cap. Flow %
1.01%
Top 10 Hldgs %
21.09%
Holding
8,715
New
425
Increased
3,806
Reduced
3,215
Closed
302
Avg Time Held
7.3 years
Top 10 Avg Time Held
6.6 years
Top 20 Avg Time Held
5.7 years

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.77B
2
MCK icon
McKesson
MCK
+$2.38B
3
SPCX icon
SpaceX
SPCX
+$2.3B
4
HONA
Honeywell Aerospace
HONA
+$2.05B
5
AMZN icon
Amazon
AMZN
+$1.37B

Sector Composition

Rank Sector Weight
1 Miscellaneous 26.02%
2 Technology 24.63%
3 Financials 9.78%
4 Healthcare 7.32%
5 Industrials 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ADUS icon
2576
Addus HomeCare
ADUS
$2.31B
$34.5M ﹤0.01%
343,822
-105,091
-23% -$9.9M
2013 Q2
52 quarters
ILCV icon
2577
iShares Morningstar Value ETF
ILCV
$1.41B
$34.5M ﹤0.01%
340,870
-11,098
-3% -$1.1M
2013 Q2
52 quarters
CAI icon
2578
Caris Life Sciences
CAI
$6.88B
$34.5M ﹤0.01%
1,935,531
+856,114
+79% +$15.3M
2025 Q2
4 quarters
PPLT icon
2579
abrdn Physical Platinum Shares ETF
PPLT
$1.79B
$34.5M ﹤0.01%
2,440,489
-393,651
-14% -$6.84M
2013 Q2
52 quarters
BUG icon
2580
Global X Cybersecurity ETF
BUG
$2.05B
$34.4M ﹤0.01%
901,711
-202,439
-18% -$6.24M
2020 Q4
22 quarters
DFIN icon
2581
Donnelley Financial Solutions
DFIN
$1.67B
$34.4M ﹤0.01%
820,801
-127,818
-13% -$5.57M
2016 Q4
38 quarters
FNCL icon
2582
Fidelity MSCI Financials Index ETF
FNCL
$2.38B
$34.4M ﹤0.01%
449,724
+66,335
+17% +$4.92M
2014 Q1
49 quarters
FXD icon
2583
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$274M
$34.4M ﹤0.01%
497,599
-6,978
-1% -$469K
2013 Q2
52 quarters
SPTI icon
2584
State Street SPDR Portfolio Intermediate Term Treasury Index ETF
SPTI
$12.1B
$34.4M ﹤0.01%
1,212,102
-132,912
-10% -$3.78M
2013 Q2
52 quarters
DLY icon
2585
DoubleLine Yield Opportunities Fund
DLY
$636M
$34.4M ﹤0.01%
2,443,074
+7,497
+0.3% +$105K
2020 Q1
25 quarters
IQQQ icon
2586
ProShares Nasdaq-100 High Income ETF
IQQQ
$372M
$34.4M ﹤0.01%
676,607
+68,587
+11% +$3.29M
2025 Q1
5 quarters
CIGI icon
2587
Colliers International
CIGI
$4.57B
$34.4M ﹤0.01%
366,443
+136,592
+59% +$13.8M
2013 Q2
52 quarters
ATRO icon
2588
Astronics
ATRO
$2.59B
$34.3M ﹤0.01%
422,557
-114,492
-21% -$7.82M
2013 Q2
52 quarters
AVNT icon
2589
Avient
AVNT
$4.17B
$34.3M ﹤0.01%
928,368
+242,925
+35% +$8.8M
2013 Q2
52 quarters
PSK icon
2590
State Street SPDR ICE Preferred Securities ETF
PSK
$607M
$34.2M ﹤0.01%
1,120,402
+54,897
+5% +$1.71M
2013 Q2
52 quarters
CCS icon
2591
Century Communities
CCS
$1.48B
$34.2M ﹤0.01%
477,074
+7,608
+2% +$440K
2014 Q3
47 quarters
VIOG icon
2592
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.06B
$34.2M ﹤0.01%
222,727
+7,141
+3% +$995K
2013 Q2
52 quarters
RNST icon
2593
Renasant Corp
RNST
$3.61B
$34.1M ﹤0.01%
801,791
+123,133
+18% +$4.98M
2013 Q2
52 quarters
UTI icon
2594
Universal Technical Institute
UTI
$1.25B
$34.1M ﹤0.01%
797,071
+254,159
+47% +$9.8M
2013 Q4
50 quarters
CPRI icon
2595
Capri Holdings
CPRI
$2.15B
$34.1M ﹤0.01%
1,835,739
+888,948
+94% +$17.1M
2013 Q2
52 quarters
USA icon
2596
Liberty All-Star Equity Fund
USA
$1.83B
$34M ﹤0.01%
5,858,880
+1,166,788
+25% +$6.73M
2013 Q2
52 quarters
NOG icon
2597
Northern Oil and Gas
NOG
$2.66B
$34M ﹤0.01%
1,873,765
-524,066
-22% -$12.4M
2013 Q2
52 quarters
ECAT icon
2598
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.29B
$34M ﹤0.01%
2,161,073
-43,395
-2% -$655K
2021 Q3
19 quarters
AZTA icon
2599
Azenta
AZTA
$1.88B
$33.9M ﹤0.01%
1,330,194
+464,585
+54% +$10.4M
2013 Q2
52 quarters
WT icon
2600
WisdomTree
WT
$3.27B
$33.9M ﹤0.01%
2,003,391
-496,731
-20% -$8.8M
2013 Q2
52 quarters

Similar funds

Morgan Stanley's Q2 2026 Portfolio in Review

As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Morgan Stanley's Q2 2026 filing shows 425 new, 3,806 increased, 3,215 reduced and 302 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.

By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
  • Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
  • Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
  • Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
  • Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
  • Morgan Stanley opened 425 new positions and closed 302 in Q2 2026.
  • Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.